COLD-SAFETY SOLUTION FOR FREEZING LEUKOCYTES AT SUB-MODERATE TEMPERATURE
FIELD: medicine, physiology. ^ SUBSTANCE: invention relates to creating cold-safety solution for freezing leukocytes and their retaining in physiologically active state after thawing. Cold-safety solution for freezing leukocytes in the ratio 1:1 at moderately low temperature and pH 7.0-7.4 contains...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine, physiology. ^ SUBSTANCE: invention relates to creating cold-safety solution for freezing leukocytes and their retaining in physiologically active state after thawing. Cold-safety solution for freezing leukocytes in the ratio 1:1 at moderately low temperature and pH 7.0-7.4 contains hexamethylene-bis-tetraoxyethylurea and water for injection. Leukocytes are frozen to -20oC being solution contains additionally hydroxymethylethylpyridine succinate in the following ratio of components, %: hexamethylene-bis-tetraoxyethylurea, 26.0-30.0; hydroxymethylethylpyridine succinate, 0.1-0.2, and water for injection, up to 100 ml. Cold-safety solution in freezing leukocytes concentrate to -20oC provides the safety of high percent of physiologically active leukocyte cells. ^ EFFECT: valuable properties of solution. ^ 3 tbl, 1 ex |
---|